US 10,376,482 B2
Butyrate and beta-hydroxybutyrate compositions
Franco Cavaleri, Surrey (CA)
Filed by Franco Cavaleri, Surrey (CA)
Filed on Jun. 21, 2016, as Appl. No. 15/187,823.
Claims priority of provisional application 62/317,607, filed on Apr. 3, 2016.
Prior Publication US 2017/0290792 A1, Oct. 12, 2017
Int. Cl. A61K 31/19 (2006.01); A61K 45/06 (2006.01); A61K 36/82 (2006.01)
CPC A61K 31/19 (2013.01) [A61K 36/82 (2013.01); A61K 45/06 (2013.01)] 8 Claims
 
1. A composition consisting essentially of:
(a) purified butyrate or esters or propionate salts thereof, wherein the purified butyrate includes a butyrate sodium salt, a butyrate calcium salt, and a butyrate magnesium salt; and
(b) purified beta-hydroxybutyrate or esters or propionate salts thereof, wherein the purified beta-hydroxybutyrate includes a beta-hydroxybutyrate sodium salt, a beta-hydroxybutyrate calcium salt, and a beta-hydroxybutyrate magnesium salt, wherein (i) the total purified butyrate to total purified beta-hydroxybutyrate ratio is about 2:1 and (ii) the composition is packaged within an oral capsule or in powdered form.